Skip to main content
. 2019 Apr 30;7:e6724. doi: 10.7717/peerj.6724

Table 1. Comparison of the clinipathological characteristics of basaloid squamous cell carcinoma (BSC), squamous cell carcinoma of the lung (SCC), large cell carcinoma of the lung (LCC) and lung adenocarcinoma (LAC).

Characteristics BSC SCC p value LCC p value LAC p value
Race, n (%) 0.351 0.039 0.049
White 358 (84.2) 75,272 (83.6) 5,682 (81.2) 128,685 (80.1)
Black 43 (10.1) 10,617 (11.8) 999 (14.3) 18,644 (11.6)
Other 24 (5.7) 4,117 (4.6) 316 (4.5) 13,309 (8.3)
Age, median [IQR] 70.15 (59.87–80.43) 70.41 (60.66–80.16) 0.139 67.92 (56.87–78.97) 0.303 68.37 (57.27–79.47) 0.376
Sex, n (%) 0.503 0.443 <0.001
Male 257 (60.5) 55,849 (62.1) 4,099 (58.6) 78,527 (48.9)
Female 168 (39.5) 34,157 (37.9) 2,898 (41.4) 82,111 (51.1)
Grade, n (%) <0.001 <0.001 <0.001
Well differetiated 2 (0.5) 1,974 (2.2) 15 (0.2) 11,955 (7.4)
Moderately differetiated 46 (10.8) 26,606 (29.6) 80 (1.1) 36,005 (22.4)
Poorly differetiated 274 (64.5) 32,307 (35.9) 2,115 (30.2) 43,291 (27.0)
Undifferetiated 13 (3.0) 648 (0.7) 2,299 (32.9) 968 (0.6)
Unknown 90 (21.2) 28,471 (31.6) 2,488 (35.6) 68,419 (42.6)
Total stage, n (%) <0.001 <0.001 <0.001
I 179 (42.1) 27,683 (30.8) 1,460 (20.9) 41,408 (25.8)
II 63 (14.8) 10,946 (12.2) 534 (7.6) 10,560 (6.6)
III 101 (23.8) 26,297 (29.2) 1,858 (26.6) 32,528 (20.2)
IV 82 (19.3) 25,080 (27.8) 3,145 (44.9) 76,142 (47.4)
T stage, n (%) <0.001 <0.001 0.001
T1 133 (31.3) 9,151 (10.2) 1,292 (10.2) 43,558 (27.1)
T2 139 (32.7) 66,275 (73.6) 2,346 (73.6) 47,776 (29.8)
T3 68 (16.0) 3,596 (4.0) 880 (4.0) 22,072 (13.7)
T4 85 (20.0) 10,984 (12.2) 2,479 (12.2) 47,232 (29.4)
N stage, n (%) <0.001 <0.001 <0.001
N0 269 (63.3) 9,151 (10.2) 2,847 (40.7) 72,104 (44.9)
N1 50 (11.8) 66,275 (73.6) 663 (9.5) 14,110 (8.8)
N2 84 (19.8) 3,596 (4.0) 2,628 (37.5) 54,487 (33.9)
N3 22 (5.1) 10,984 (12.2) 859 (12.3) 19,937 (12.4)
M stage, n (%) <0.001 <0.001 <0.001
M0 343 (80.7) 58,972 (65.5) 3,854 (55.1) 84,496 (52.6)
M1 82 (19.3) 31,034 (34.5) 3,143 (44.9) 76,142 (47.4)
Surgery, n (%) <0.001 <0.001 <0.001
Not performed 144 (33.9) 60,336 (67.0) 5,041 (72.0) 112,857 (70.3)
Lobectomy 199 (46.8) 20,978 (23.3) 1,377 (19.7) 35,329 (22.0)
Sublobar resection 62 (14.6) 6,153 (6.8) 438 (6.3) 10,982 (6.8)
Pneumonectomy 20 (4.7) 2,539 (2.8) 141 (2.0) 1,470 (0.9)
Radiotherapy, n (%) <0.001 <0.001 <0.001
No 104 (24.5) 4 (0.0) 3,980 (56.9) 98,823 (61.5)
Yes 321 (75.5) 90,002 (100.0) 3,017 (43.1) 61,815 (38.5)
Chemotherapy, n (%) <0.001 <0.001 <0.001
No 134 (31.5) 53,403 (59.3) 3,944 (56.4) 88,220 (54.9)
Yes 291 (68.5) 36,603 (40.7) 3,053 (43.6) 72,418 (45.1)

Notes.

P value for chi-square test.

BSC
Basaloid squamous cell carcinoma
SCC
squamous cell carcinoma
LCC
large cell carcinoma of the lung
LAC
lung adenocarcinoma
IQR
interquartile range